Lars Herfindal Selected Research

Cytarabine (Cytosar-U)

2/2002

Use of marine toxins in combination with cytotoxic drugs for induction of apoptosis in acute myelogenous leukaemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Herfindal Research Topics

Disease

15	Neoplasms (Cancer) 12/2022 - 09/2009
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 01/2013
3	Leukemia 01/2017 - 10/2010
2	Cardiotoxicity 12/2022 - 01/2016
2	Hypoxia (Hypoxemia) 04/2021 - 01/2017
1	Multiple Sclerosis 11/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2021
1	Breast Neoplasms (Breast Cancer) 11/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Neurologic Manifestations (Neurological Manifestations) 01/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2013
1	T-Cell Lymphoma (Lymphoma, T Cell) 04/2011
1	Poisoning 07/2010
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2002

Drug/Important Bio-Agent (IBA)

3	Liposomes (Liposome)IBA 12/2022 - 01/2016
3	iodininIBA 04/2021 - 01/2013
2	AnthracyclinesIBA 12/2022 - 01/2016
2	GraphiteIBA 03/2022 - 09/2021
2	Drug CarriersIBA 03/2022 - 09/2021
2	Phenformin (Fenformin)IBA 03/2022 - 09/2021
2	OxidesIBA 04/2021 - 01/2017
2	myxinIBA 04/2021 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2013
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2013 - 10/2010
1	NitrogenIBA 03/2024
1	Protein Kinases (Protein Kinase)IBA 03/2024
1	rac1 GTP-Binding ProteinIBA 01/2024
1	GTP Phosphohydrolases (GTPases)IBA 01/2024
1	Monoclonal AntibodiesIBA 11/2023
1	Rituximab (Mabthera)FDA Link 11/2023
1	ofatumumab FDA Link 11/2023
1	ocrelizumabIBA 11/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2022
1	CholesterolIBA 12/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022
1	Simvastatin (Zocor)FDA LinkGeneric 12/2022
1	Peptides (Polypeptides)IBA 10/2021
1	ProdrugsIBA 04/2021
1	phenazine di-N-oxideIBA 04/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2020
1	Antipsychotic Agents (Antipsychotics)IBA 06/2020
1	Chlorpromazine (Thorazine)FDA Link 06/2020
1	MethyltransferasesIBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	CytochromesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Cytotoxins (Cytolysins)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	Oxygen (Dioxygen)IBA 01/2017
1	Polystyrenes (Polystyrene)IBA 01/2016
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 01/2016
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 10/2015
1	Cyclic NucleotidesIBA 01/2014
1	NucleotidesIBA 01/2014
1	Cyclic PeptidesIBA 04/2011
1	microcystinIBA 04/2011
1	MicrocystinsIBA 07/2010
1	EstersIBA 09/2009
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2002

Therapy/Procedure

7	Therapeutics 12/2022 - 01/2013
1	Transplantation 11/2020
1	Combined Modality Therapy 01/2020
1	Enzyme Replacement Therapy 01/2018
1	Aftercare (After-Treatment) 02/2002